IL162271A0 - Pharmaceutical dosage form and method for the production thereof - Google Patents
Pharmaceutical dosage form and method for the production thereofInfo
- Publication number
- IL162271A0 IL162271A0 IL16227103A IL16227103A IL162271A0 IL 162271 A0 IL162271 A0 IL 162271A0 IL 16227103 A IL16227103 A IL 16227103A IL 16227103 A IL16227103 A IL 16227103A IL 162271 A0 IL162271 A0 IL 162271A0
- Authority
- IL
- Israel
- Prior art keywords
- copolymer
- active ingredient
- pellets
- tablets
- dosage form
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10208335A DE10208335A1 (de) | 2002-02-27 | 2002-02-27 | Arzneiform und Verfahren zu ihrer Herstellung |
PCT/EP2003/000934 WO2003072087A1 (de) | 2002-02-27 | 2003-01-30 | Azneiform und verfahren ihrer herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
IL162271A0 true IL162271A0 (en) | 2005-11-20 |
Family
ID=27675016
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16227103A IL162271A0 (en) | 2002-02-27 | 2003-01-30 | Pharmaceutical dosage form and method for the production thereof |
IL162271A IL162271A (en) | 2002-02-27 | 2004-06-01 | Process for producing a drug |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL162271A IL162271A (en) | 2002-02-27 | 2004-06-01 | Process for producing a drug |
Country Status (14)
Country | Link |
---|---|
US (1) | US7833546B2 (xx) |
EP (1) | EP1478352B1 (xx) |
JP (1) | JP4653399B2 (xx) |
KR (1) | KR100784657B1 (xx) |
AT (1) | ATE336232T1 (xx) |
AU (1) | AU2003218641A1 (xx) |
BR (1) | BR0308006A (xx) |
CA (1) | CA2476972A1 (xx) |
DE (2) | DE10208335A1 (xx) |
ES (1) | ES2272955T3 (xx) |
IL (2) | IL162271A0 (xx) |
MX (1) | MXPA04008344A (xx) |
PL (1) | PL370425A1 (xx) |
WO (1) | WO2003072087A1 (xx) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10220470A1 (de) * | 2002-04-30 | 2003-11-20 | Roehm Gmbh | ph-sensitives Polymer |
IL130602A0 (en) | 1999-06-22 | 2000-06-01 | Dexcel Ltd | Stable benzimidazole formulation |
DE19961334A1 (de) * | 1999-12-17 | 2001-06-21 | Roehm Gmbh | Spritzgußverfahren für neutrale und säuregruppenhaltige (Meth)acrylat-Copolymere |
DE10011447A1 (de) * | 2000-03-10 | 2001-09-20 | Roehm Gmbh | Dispersion mit nichtionischem Emulgator |
CA2359812C (en) * | 2000-11-20 | 2004-02-10 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures |
DE10127134A1 (de) * | 2001-06-05 | 2002-12-12 | Roehm Gmbh | verfahren zur Herstellung von Formkörpern aus (Meth)acrylat-Copolymeren mittels Spritzguß |
DE10214002A1 (de) * | 2002-03-27 | 2003-10-09 | Roehm Gmbh | Pharmazeutische Formulierung für den Wirkstoff Budesonid |
MXPA04010956A (es) * | 2003-01-30 | 2005-01-25 | Roehm Gmbh | Forma de dosis farmaceutica y metodo para la produccion de la misma. |
EP1523981A1 (en) * | 2003-10-13 | 2005-04-20 | Wyeth | Extended release formulations of venlafaxine |
EP1523979A1 (en) * | 2003-10-13 | 2005-04-20 | Wyeth | Extended release pharmaceutical dosage form |
KR100720817B1 (ko) | 2003-12-26 | 2007-05-21 | (주)아모레퍼시픽 | 식물 추출물을 함유하는 제제 및 그 제조방법 |
CA2575988C (en) | 2004-08-04 | 2014-02-18 | Brookwood Pharmaceuticals, Inc. | Methods for manufacturing delivery devices and devices thereof |
DE102005007059A1 (de) * | 2005-02-15 | 2006-08-24 | Röhm GmbH & Co. KG | Teilneutralisiertes anionisches (Meth)acrylat-Copolymer |
EP2457564A1 (en) * | 2005-03-11 | 2012-05-30 | Endo Pharmaceuticals Solutions Inc. | Controlled release formulations of octreotide |
US7759312B2 (en) * | 2005-03-11 | 2010-07-20 | Endo Pharmaceuticals Solutions Inc. | Delivery of dry formulations of octreotide |
US8536298B2 (en) | 2005-05-25 | 2013-09-17 | Sabic Innovative Platics Ip B.V. | Precipitative process to prepare polyimides |
DE102005032806A1 (de) * | 2005-07-12 | 2007-01-18 | Röhm Gmbh | Verwendung eines teilneutralisierten, anionischen (Meth)acrylat-Copolymers als Überzug für die Herstellung einer Arzneiform mit einer Wirkstofffreisetzung bei erniedrigten pH-Werten |
JP2009527504A (ja) * | 2006-02-23 | 2009-07-30 | イオメディックス スリープ インターナショナル エスアールエル | 良質な睡眠の誘導および維持のための組成物および方法 |
DE102007009243A1 (de) | 2007-02-22 | 2008-09-18 | Evonik Röhm Gmbh | Pellets mit einer Wirkstoff-Matrix und einem Polymerüberzug, sowie ein Verfahren zur Herstellung der Pellets |
DE102007009242A1 (de) | 2007-02-22 | 2008-09-18 | Evonik Röhm Gmbh | Pellets mit magensaftresistenter Wirkstoff-Matix |
MX2009011641A (es) * | 2007-04-27 | 2010-03-04 | Endo Pharmaceuticals Solutions | Agentes de liberacion para dispositivo de implante y metodos para utilizar los mismos. |
SI2152250T1 (sl) * | 2007-05-07 | 2020-06-30 | Evonik Operations Gmbh | Trdne dozirne oblike, ki vsebujejo enterično oplaščenje s pospešenim sproščanjem zdravila |
CA2696341C (en) * | 2007-08-13 | 2016-05-17 | Abuse Deterrent Pharmaceutical Llc | Abuse resistant drugs, method of use and method of making |
US8124601B2 (en) * | 2007-11-21 | 2012-02-28 | Bristol-Myers Squibb Company | Compounds for the treatment of Hepatitis C |
US8728528B2 (en) | 2007-12-20 | 2014-05-20 | Evonik Corporation | Process for preparing microparticles having a low residual solvent volume |
TWI441658B (zh) | 2008-03-11 | 2014-06-21 | Takeda Pharmaceutical | 口腔崩解固體製劑 |
JP5622725B2 (ja) | 2008-06-25 | 2014-11-12 | エンド ファーマスーティカルズ ソリューションズ インコーポレイテッド.Endo Pharmaceuticals Solutionsinc. | エキセナチド及び他のポリペプチド類の持続的送達 |
WO2009158415A1 (en) * | 2008-06-25 | 2009-12-30 | Endo Pharmaceuticals Solutions Inc. | Octreotide implant having a release agent |
US9730899B2 (en) | 2009-03-18 | 2017-08-15 | Evonik Roehm Gmbh | Controlled release pharmaceutical composition with resistance against the influence of ethanol employing a coating comprising neutral vinyl polymers and excipients |
EP2408437A1 (en) * | 2009-03-18 | 2012-01-25 | Evonik Röhm GmbH | Controlled release pharmaceutical composition with resistance against the influence of ethanol employing a coating comprising a polymer mixture and excipients |
DE102009028076A1 (de) | 2009-07-29 | 2011-02-03 | Evonik Röhm Gmbh | Beschichtungsmittel zum Tauchbeschichten von Kapselhälften |
US9107451B2 (en) | 2009-07-29 | 2015-08-18 | Evonik Röhm Gmbh | Coating composition for the dip coating of capsule halves |
US8962064B2 (en) | 2011-02-28 | 2015-02-24 | Basf Se | Production of pulverulent coating compositions for stable protective coatings for pharmaceutical dosage forms |
JP6027550B2 (ja) * | 2011-02-28 | 2016-11-16 | ビーエーエスエフ ソシエタス・ヨーロピアBasf Se | 医薬剤形用の安定した保護被覆のための粉末被覆剤の製造 |
TWI535461B (zh) | 2011-03-11 | 2016-06-01 | 諾金私人有限公司 | 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法 |
US9775815B2 (en) | 2011-06-17 | 2017-10-03 | Evonik Roehm Gmbh | Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol |
PL2720681T3 (pl) | 2011-06-17 | 2017-05-31 | Evonik Röhm Gmbh | Kompozycja powlekająca odpowiednia do farmaceutycznych lub nutraceutycznych postaci dawkowania |
KR101799624B1 (ko) | 2011-06-17 | 2017-11-20 | 에보니크 룀 게엠베하 | 제약 또는 기능식품 투여 형태에 적합한 코팅 조성물 |
US20130143867A1 (en) | 2011-12-02 | 2013-06-06 | Sychroneuron Inc. | Acamprosate formulations, methods of using the same, and combinations comprising the same |
DE102012009057A1 (de) | 2012-05-09 | 2013-11-14 | Dr. Arabin GmbH & Co. KG | Rotationspessar mit zusätzlicher Wirkstoffkomponente |
MY174758A (en) | 2012-09-11 | 2020-05-13 | Norgine Bv | Compositions comprising peg and ascorbate |
US20140141075A1 (en) | 2012-11-21 | 2014-05-22 | Warner Chilcott Company, Llc | 5-aminosalicylic acid capsule formulation |
JP2016520653A (ja) | 2013-06-05 | 2016-07-14 | シンクロニューロン インコーポレイテッド | アカンプロサート製剤、それを用いる方法、およびそれを含む合剤 |
CN103536538B (zh) * | 2013-10-23 | 2016-06-29 | 海南康芝药业股份有限公司 | 一种有效掩味的膨胀性微丸及其制备方法 |
US9750785B2 (en) | 2015-01-30 | 2017-09-05 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9744209B2 (en) | 2015-01-30 | 2017-08-29 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9744239B2 (en) | 2015-01-30 | 2017-08-29 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9687526B2 (en) | 2015-01-30 | 2017-06-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9937223B2 (en) | 2015-01-30 | 2018-04-10 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9925233B2 (en) | 2015-01-30 | 2018-03-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
JP2022529781A (ja) | 2019-04-17 | 2022-06-24 | コンパス パスファインダー リミテッド | サイロシビンによるうつ病及び他の様々な障害の治療 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4402666A1 (de) * | 1994-01-29 | 1995-08-03 | Roehm Gmbh | Verfahren zum kurzzeitigen Behandeln einer Kunststoffschmelze mit einem flüssigen Behandlungsmittel und dabei hergestellter thermoplastischer Kunststoff |
DE9414065U1 (de) | 1994-08-31 | 1994-11-03 | Roehm Gmbh | Thermoplastischer Kunststoff für darmsaftlösliche Arznei-Umhüllungen |
DE9414066U1 (de) | 1994-08-31 | 1994-11-03 | Roehm Gmbh | Überzugs- und Bindemittel für Arzneiformen sowie damit hergestellte Arzneiform |
DE29502547U1 (de) * | 1995-02-16 | 1995-03-30 | Roehm Gmbh | Thermoplastisches Überzugs- und Bindemittel für Arzneiformen |
DE19544562B4 (de) * | 1995-11-30 | 2004-05-27 | Röhm GmbH & Co. KG | Verfahren zur Herstellung von Poly(meth)acrylimiden mit bei thermischer Belastung verbesserter Farbstabilität und daraus erhältliche Formkörper |
DE19653605C2 (de) * | 1996-12-20 | 2002-11-28 | Roehm Gmbh | Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems |
DE19653606A1 (de) * | 1996-12-20 | 1998-06-25 | Roehm Gmbh | Haft- und Bindemittel aus (Meth)acrylatpolymer, organischer Säure und Weichmacher |
DE19718597C1 (de) * | 1997-05-02 | 1999-01-07 | Roehm Gmbh | Zweistufiges Verfahren zur Entwässerung von Kunststoffdispersionen |
KR100542421B1 (ko) * | 1998-09-18 | 2006-01-11 | 룀 게엠베하 운트 콤파니 카게 | 정보 반송 디스크 블랭크 제조용 금형 장치 |
DE19845358A1 (de) * | 1998-10-02 | 2000-04-06 | Roehm Gmbh | Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe |
DE10220470A1 (de) * | 2002-04-30 | 2003-11-20 | Roehm Gmbh | ph-sensitives Polymer |
DE19958007A1 (de) * | 1999-12-02 | 2001-06-07 | Roehm Gmbh | Spritzgußverfahren für (Meth)acrylat-Copolymere mit teritiären Ammoniumgruppen |
DE19961334A1 (de) * | 1999-12-17 | 2001-06-21 | Roehm Gmbh | Spritzgußverfahren für neutrale und säuregruppenhaltige (Meth)acrylat-Copolymere |
DE10011447A1 (de) * | 2000-03-10 | 2001-09-20 | Roehm Gmbh | Dispersion mit nichtionischem Emulgator |
DE10013029A1 (de) * | 2000-03-17 | 2001-09-20 | Roehm Gmbh | Mehrschichtige Arzneiform für die Colonfreigabe |
DE10065492A1 (de) * | 2000-12-28 | 2003-06-26 | Roehm Gmbh | Diffus ausgestattete Formmassen und hieraus erhältliche Formkörper |
JP2004517157A (ja) * | 2001-01-29 | 2004-06-10 | レーム ゲゼルシヤフト ミツト ベシユレンクテル ハフツング ウント コンパニー コマンディートゲゼルシャフト | 薬学的適用のための貯蔵安定性接着および結合剤 |
WO2002060415A1 (de) * | 2001-01-31 | 2002-08-08 | Röhm GmbH & Co. KG | Multipartikuläre arzneiform, enthaltend mindestens zwei unterschiedlich überzogene pelletformen |
DE10127134A1 (de) * | 2001-06-05 | 2002-12-12 | Roehm Gmbh | verfahren zur Herstellung von Formkörpern aus (Meth)acrylat-Copolymeren mittels Spritzguß |
DE10214002A1 (de) * | 2002-03-27 | 2003-10-09 | Roehm Gmbh | Pharmazeutische Formulierung für den Wirkstoff Budesonid |
-
2002
- 2002-02-27 DE DE10208335A patent/DE10208335A1/de not_active Withdrawn
-
2003
- 2003-01-30 BR BR0308006-4A patent/BR0308006A/pt not_active Application Discontinuation
- 2003-01-30 KR KR1020047013492A patent/KR100784657B1/ko not_active IP Right Cessation
- 2003-01-30 ES ES03711870T patent/ES2272955T3/es not_active Expired - Lifetime
- 2003-01-30 MX MXPA04008344A patent/MXPA04008344A/es active IP Right Grant
- 2003-01-30 AU AU2003218641A patent/AU2003218641A1/en not_active Abandoned
- 2003-01-30 PL PL03370425A patent/PL370425A1/xx not_active Application Discontinuation
- 2003-01-30 DE DE50304658T patent/DE50304658D1/de not_active Expired - Lifetime
- 2003-01-30 JP JP2003570833A patent/JP4653399B2/ja not_active Expired - Lifetime
- 2003-01-30 IL IL16227103A patent/IL162271A0/xx unknown
- 2003-01-30 WO PCT/EP2003/000934 patent/WO2003072087A1/de active IP Right Grant
- 2003-01-30 AT AT03711870T patent/ATE336232T1/de active
- 2003-01-30 US US10/502,648 patent/US7833546B2/en active Active
- 2003-01-30 CA CA002476972A patent/CA2476972A1/en not_active Abandoned
- 2003-01-30 EP EP03711870A patent/EP1478352B1/de not_active Expired - Lifetime
-
2004
- 2004-06-01 IL IL162271A patent/IL162271A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2003072087A1 (de) | 2003-09-04 |
DE50304658D1 (de) | 2006-09-28 |
DE10208335A1 (de) | 2003-09-04 |
KR100784657B1 (ko) | 2007-12-12 |
BR0308006A (pt) | 2005-01-04 |
IL162271A (en) | 2009-06-15 |
EP1478352B1 (de) | 2006-08-16 |
JP4653399B2 (ja) | 2011-03-16 |
MXPA04008344A (es) | 2004-11-26 |
JP2005526546A (ja) | 2005-09-08 |
PL370425A1 (en) | 2005-05-30 |
AU2003218641A1 (en) | 2003-09-09 |
US7833546B2 (en) | 2010-11-16 |
ATE336232T1 (de) | 2006-09-15 |
US20050079216A1 (en) | 2005-04-14 |
ES2272955T3 (es) | 2007-05-01 |
CA2476972A1 (en) | 2003-09-04 |
KR20040098007A (ko) | 2004-11-18 |
EP1478352A1 (de) | 2004-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL162271A0 (en) | Pharmaceutical dosage form and method for the production thereof | |
SI1496870T1 (sl) | Zdravilna oblika in postopek za njeno pripravo | |
WO2005009357A3 (en) | Controlled release compositions | |
TW200635617A (en) | Multiparticulate pharmaceutical form comprising mucoadhesively formulated nucleic acid active ingredients, and a process for producing the pharmaceutical form | |
KR890001526A (ko) | 경구용 서방성 아세트 아미노펜 제형 및 이의 제조방법 | |
BR9808429A (pt) | Composição farmacêutica e processo para a sua preparação. | |
HK1010835A1 (en) | Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors | |
PT1309315E (pt) | Formulacao oral de desintegracao rapida de valdecoxib | |
BR9912353A (pt) | Agente de revestimento e aglutinante para formas de medicamento orais e dérmicas | |
NZ505431A (en) | Solid thermoformable controlled-release pharmaceutical composition | |
MXPA04003970A (es) | Granulos o polvo para la produccion de agentes de recubrimiento y aglutinantes para formas farmaceuticas. | |
CA2566931A1 (en) | Tablets exhibiting reduced drug release variability | |
DE50307321D1 (de) | Schmelzextrusion von wirkstoffsalzen | |
WO2006050002A3 (en) | Compositions for controlled delivery of pharmaceutically active compounds | |
EP2837376A3 (de) | Kompaktiertes Moxifloxacin | |
TW200624127A (en) | New modified release pellet formulations for proton pump inhibitors | |
TN2009000197A1 (en) | Sustained - release composition and method for producing the same | |
CA2339913A1 (en) | Pharmaceutical formulations and method for making | |
CA2194610A1 (en) | Sustained-Release Formulation of Animal Growth Hormone and Process for Preparation Thereof | |
WO2005115346A3 (en) | Pharmaceutical composition containing risperidone | |
WO2006123360A3 (en) | Microspheres containing octreotide acetate | |
WO2008055254A3 (en) | Formulations and methods for oral delivery of proteins | |
DE60220551D1 (de) | Tabletten mit verzögerter wirkstofffreisetzung enthaltend indapamid | |
WO2004098562A3 (en) | Controlled release solid dosage nifedipine formulations | |
MD1779G2 (ro) | Compoziţie dermatologică peliculogenă cu juglonă (variante) |